New hope for tough cancers: first human test of experimental drug begins
NCT ID NCT04396821
Summary
This early-stage trial is testing a new drug called TST001 for people with advanced stomach, gastroesophageal junction, or pancreatic cancer. The main goals are to find a safe dose and see how well the body handles the drug, both alone and when combined with other standard cancer treatments. It is enrolling about 150 adults whose cancer has spread or cannot be removed by surgery.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Allegheny Hospital
Pittsburgh, Pennsylvania, 15212, United States
-
Banner MD Anderson
Gilbert, Arizona, 85234, United States
-
Emory University
Atlanta, Georgia, 30033, United States
-
Florida Cancer Specialists
Sarasota, Florida, 34232, United States
-
Gabrail Cancer Research
Canton, Ohio, 44718, United States
-
Medical College of Wisconsin
Milwaukee, Wisconsin, 53226, United States
-
Memorial Sloan Kettering
New York, New York, 10065, United States
-
NEXT Oncology
Austin, Texas, 78704, United States
-
Pennsylvania Cancer Specialist Research Institute
Gettysburg, Pennsylvania, 17325, United States
-
Sarah Cannon Research Institute
Nashville, Tennessee, 37203, United States
-
Stony Brook Cancer Center
Stony Brook, New York, 11794, United States
-
Swedish Cancer Institute
Seattle, Washington, 98104, United States
-
University of Arizona
Tucson, Arizona, 85724, United States
-
University of Kansas, School of Medicine
Kansas City, Kansas, 66160, United States
-
Vanderbilt University
Nashville, Tennessee, 37232, United States
-
Wake Forest Baptist Comprehensive Cancer Center
Winston-Salem, North Carolina, 27157, United States
-
Washington University
St Louis, Missouri, 63110, United States
-
Yale University
New Haven, Connecticut, 06519, United States
Conditions
Explore the condition pages connected to this study.